VALERIE WALLACE: Open Payments
NPI 1902375512 · CHESTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 12 payments from 5 companies in 2025. Trend: 2023 $142 · 2024 $376 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $100 |
| Novo Nordisk Inc | 3 | $92 |
| ABBVIE INC. | 4 | $83 |
| Lilly USA, LLC | 3 | $69 |
| Fidia Pharma USA Inc. | 1 | $16 |
Products named: AIRSUPRA, UBRELVY, MOUNJARO, Rybelsus, Ozempic, Wegovy, QULIPTA, HYMOVIS.
Industry payments across MD — which companies pay providers there.
